New hope for breast cancer patients who Can't tolerate standard hormone therapy
NCT ID NCT07541079
First seen Apr 30, 2026 · Last updated Jun 17, 2026 · Updated 7 times
Summary
This study is for 300 women with early-stage, hormone-sensitive breast cancer who had to stop their usual hormone pills due to side effects. It tests a different drug, giredestrant, to see if women stick with it and how it affects their symptoms and quality of life. The goal is to find a better-tolerated option to help prevent cancer from coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.